The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Effective disaster response and management is a collaborative work
Survey of Unmet Needs in chronic myeloid leukemia (CML SUN) data signal need for amplified patient voice during treatment discussions that balance quality of life (QoL), efficacy, and tolerability goals across all lines of therapy
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Subscribe To Our Newsletter & Stay Updated
